Title |
Engineering CAR-T cells
|
---|---|
Published in |
Biomarker Research, June 2017
|
DOI | 10.1186/s40364-017-0102-y |
Pubmed ID | |
Authors |
Cheng Zhang, Jun Liu, Jiang F. Zhong, Xi Zhang |
Abstract |
Chimeric antigen receptor redirected T cells (CAR-T cells) have achieved inspiring outcomes in patients with B cell malignancies, and are now being investigated in other hematologic malignancies and solid tumors. CAR-T cells are generated by the T cells from patients' or donors' blood. After the T cells are expanded and genetically modified, they are reinfused into the patients. However, many challenges still need to be resolved in order for this technology to gain widespread adoption. In this review, we first discuss the structure and evolution of chimeric antigen receptors. We then report on the tools used for production of CAR-T cells. Finally, we address the challenges posed by CAR-T cells. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1304 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 262 | 20% |
Student > Master | 159 | 12% |
Researcher | 115 | 9% |
Student > Ph. D. Student | 110 | 8% |
Student > Doctoral Student | 50 | 4% |
Other | 109 | 8% |
Unknown | 499 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 313 | 24% |
Immunology and Microbiology | 111 | 9% |
Medicine and Dentistry | 99 | 8% |
Agricultural and Biological Sciences | 74 | 6% |
Engineering | 43 | 3% |
Other | 127 | 10% |
Unknown | 537 | 41% |